MarketersMEDIA / Newsroom / Regenerative Medicine Market 2018 Global Regional Outlook, End User, Innovation, Strategy, Size, Share, Growth Opportunities, Latest Trends Forecast to 2023

Regenerative Medicine Market 2018 Global Regional Outlook, End User, Innovation, Strategy, Size, Share, Growth Opportunities, Latest Trends Forecast to 2023

Share This Press Release

A new market study, titled “Regenerative Medicine Market Research Report-Global Forecast To 2022” has been featured on Market Research Future.

— The Global Regenerative Medicine Market is prognosticated to mark an exponential CAGR of 25.4% during the forecast period 2016 to 2022. The popularity of regenerative medicine is growing owing to the large-scale prevalence of chronic diseases such as cancer, cirrhosis, etc. Other factors projected to catalyze the growth of the market include developments in nanotechnology, increasing incidence of degenerative diseases, etc. This has led to a drastic increase in the research and development initiatives undertaken globally for the development of effective drugs.

Get Sample Copy @ https://www.marketresearchfuture.com/sample_request/2220

Investments are likely to flow towards the regenerative medicine market over the next couple of years. In addition, the support extended by the government for drug development is poised to revolutionize the future trajectory of the global market. It is also likely to benefit from technological advancements in the market.

 Stem cell technology is gaining traction in the healthcare sector. Its accelerated adoption in the field of medical science is also anticipated to have a favorable impact on the expansion of the regenerative medicine market. The players of the market are forecasted to capitalize on the gap prevailing between the demand and supply for organs. However, factors such as stringent regulations, and the high cost of the treatment are expected to check the proliferation of the regenerative medicine market through the projection period.

Competitive Dashboard:

Some of the key players profiled in the report are Cook Biotech, Organogenesis, Stryker and RTI surgical, Baxter International, Inc., Osiris Therapeutics, CryoLife, Sanofi, LifeSciences, Advanced Cell Technology, BioMimetic Therapeutics, LifeCell Kinetic Concepts, StemCellsInc, and Medtronic.

Market Segmentation:

on the basis of material, the regenerative medicine market has been segmented into synthetic materials, genetically engineered materials, pharmaceuticals, biologically derived materials, and others.

On the basis of therapy, the global regenerative medicine market has been segmented into stem cell biology, cellular therapy, tissue engineering, and others.

On the basis of application, the regenerative medicine market has been segmented into cord blood, oncology, urology, orthopedics, neurology, dermatology, cardiovascular, orthopedic and others.

Regional Analysis:

The global regenerative medicine market, by region, has been segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. North America is currently holding the largest share of the market, accounting for 44% share. It is expected to grow significantly at a CAGR of 22.3% during the forecast period. The factors such as developments in healthcare technology, presence of advanced healthcare infrastructure, increasing burden of chronic diseases, etc.

Europe has gained control over the second-largest share of the market. It is expected to strike a high CAGR of 22.5% over the assessment period. The availability of funds coupled with the government’s support is likely to accelerate research & development activities. This, in turn, is prognosticated to boost the growth trajectory of the regional regenerative medicine market in the upcoming years.

Asia Pacific is a highly lucrative market and is expected to remain so across the review period. The rapid developments in the healthcare sector and growing patient pool are anticipated to drive the expansion of the regenerative medicine market in the region. It is estimated to mark a relatively higher CAGR and emerge as the fastest growing regional market in the foreseeable future.

Industry News:

In November 2018, 3D.FAB, a French additive manufacturing platform, has announced that it is working on the development of a “living bandage” using direct additive manufacturing and 3D bioprinting for treating damaged tissues.

In December 2018, Food and Drug Administration has sent Genetech, a CA-based biotechnology subsidiary of Roche, and other firms and providers offering stem cell treatments warning letters to notify about agency's regenerative medicine policy framework.

Browse Complete 80 Pages Premium Research Report Enabled with Respective Tables and Figures @ https://www.marketresearchfuture.com/reports/regenerative-medicine-market-2220

About US:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact Info:
Name: Market Research Future
Email: Send Email
Organization: Market Research Future
Address: Contact Us:, https://www.marketresearchfuture.com, Office No. 528, Amanora Chambers, Magarpatta Road, Hadapsar,, Pune - 411028, Maharashtra, India, Phone: +1 646 845 9312, Email: sales@marketresearchfuture.com
Phone: +1 646 845 9312
Website: https://www.marketresearchfuture.com/reports/regenerative-medicine-market-2220

Source URL: https://marketersmedia.com/regenerative-medicine-market-2018-global-regional-outlook-end-user-innovation-strategy-size-share-growth-opportunities-latest-trends-forecast-to-2023/481665

Source: MarketersMedia

Release ID: 481665

Latest Releases

Subscribe and Receive exclusive insider tips and tricks on Press Release.

Follow Us

Copyright © 2012 - 2019 MarketersMEDIA – Press Release Distribution Services – News Release Distribution Services. All Rights Reserved.

Powered by Semantics BigData Analytics (SBDA).